132 related articles for article (PubMed ID: 30673275)
1. Histidine-Rich Cell-Penetrating Peptide for Cancer Drug Delivery and Its Uptake Mechanism.
Zhang L; Xu J; Wang F; Ding Y; Wang T; Jin G; Martz M; Gui Z; Ouyang P; Chen P
Langmuir; 2019 Mar; 35(9):3513-3523. PubMed ID: 30673275
[TBL] [Abstract][Full Text] [Related]
2. Molecular binding of self-assembling peptide EAK16-II with anticancer agent EPT and its implication in cancer cell inhibition.
Lu S; Wang H; Sheng Y; Liu M; Chen P
J Control Release; 2012 May; 160(1):33-40. PubMed ID: 22465389
[TBL] [Abstract][Full Text] [Related]
3. Design and Characterization of a Multifunctional pH-Triggered Peptide C8 for Selective Anticancer Activity.
Lu S; Bennett WF; Ding Y; Zhang L; Fan HY; Zhao D; Zheng T; Ouyang PK; Li J; Wu Y; Xu W; Chu D; Yuan Y; Heerklotz H; Karttunen M; Chen P
Adv Healthc Mater; 2015 Dec; 4(17):2709-18. PubMed ID: 26474414
[TBL] [Abstract][Full Text] [Related]
4. Design of a new pH-activatable cell-penetrating peptide for drug delivery into tumor cells.
Zhang Y; Li L; Chang L; Liu H; Song J; Liu Y; Bao H; Liu B; Wang R; Ni J
Chem Biol Drug Des; 2019 Sep; 94(5):1884-1893. PubMed ID: 31062442
[TBL] [Abstract][Full Text] [Related]
5. Surface-assisted assembly of a histidine-rich lipidated peptide for simultaneous exfoliation of graphite and functionalization of graphene nanosheets.
Zhang L; Sheng Y; Zehtab Yazdi A; Sarikhani K; Wang F; Jiang Y; Liu J; Zheng T; Wang W; Ouyang P; Chen P
Nanoscale; 2019 Feb; 11(6):2999-3012. PubMed ID: 30698183
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylation of Membrane-Penetrating Magainin Derivatives Reinforces Necroptosis in A549 Cells Dependent on Peptide Conformational Propensities.
Behzadi M; Arasteh S; Bagheri M
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56815-56829. PubMed ID: 33296603
[TBL] [Abstract][Full Text] [Related]
7. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs.
Figueiredo P; Ferro C; Kemell M; Liu Z; Kiriazis A; Lintinen K; Florindo HF; Yli-Kauhaluoma J; Hirvonen J; Kostiainen MA; Santos HA
Nanomedicine (Lond); 2017 Nov; 12(21):2581-2596. PubMed ID: 28960138
[TBL] [Abstract][Full Text] [Related]
8. Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.
Wu Y; Sadatmousavi P; Wang R; Lu S; Yuan YF; Chen P
Int J Nanomedicine; 2012; 7():3221-33. PubMed ID: 22802684
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive PepFect cell-penetrating peptides.
Regberg J; Vasconcelos L; Madani F; Langel Ü; Hällbrink M
Int J Pharm; 2016 Mar; 501(1-2):32-8. PubMed ID: 26821060
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species-responsive amino acid-based polymeric nanovehicles for tumor-selective anticancer drug delivery.
Yuan Y; Zhao L; Shen C; He Y; Yang F; Zhang G; Jia M; Zeng R; Li C; Qiao R
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110159. PubMed ID: 31753404
[TBL] [Abstract][Full Text] [Related]
12. Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular Delivery of Functional siRNA to Triple Negative Breast Cancer Cells.
Biswas A; Chakraborty K; Dutta C; Mukherjee S; Gayen P; Jan S; Mallick AM; Bhattacharyya D; Sinha Roy R
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4719-4736. PubMed ID: 30628773
[TBL] [Abstract][Full Text] [Related]
13. Chitosan oligosaccharide-based dual pH responsive nano-micelles for targeted delivery of hydrophobic drugs.
Wang Y; Khan A; Liu Y; Feng J; Dai L; Wang G; Alam N; Tong L; Ni Y
Carbohydr Polym; 2019 Nov; 223():115061. PubMed ID: 31426963
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery with nanospherical supramolecular cell penetrating peptide-taxol conjugates containing a high drug loading.
Tian R; Wang H; Niu R; Ding D
J Colloid Interface Sci; 2015 Sep; 453():15-20. PubMed ID: 25956129
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.
Masood F; Chen P; Yasin T; Fatima N; Hasan F; Hameed A
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1054-60. PubMed ID: 23827542
[TBL] [Abstract][Full Text] [Related]
17. Poly(PEGA)-b-poly(L-lysine)-b-poly(L-histidine) Hybrid Vesicles for Tumoral pH-Triggered Intracellular Delivery of Doxorubicin Hydrochloride.
Johnson RP; Uthaman S; John JV; Lee HR; Lee SJ; Park H; Park IK; Suh H; Kim I
ACS Appl Mater Interfaces; 2015 Oct; 7(39):21770-9. PubMed ID: 26375278
[TBL] [Abstract][Full Text] [Related]
18. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of peptide mediated delivery of anticancer drug ellipticine.
Ma W; Lu S; Pan P; Sadatmousavi P; Yuan Y; Chen P
PLoS One; 2012; 7(8):e43684. PubMed ID: 22952737
[TBL] [Abstract][Full Text] [Related]
20. Release of hydrophobic anticancer drug from a newly designed self-assembling peptide.
Wu M; Ye Z; Liu Y; Liu B; Zhao X
Mol Biosyst; 2011 Jun; 7(6):2040-7. PubMed ID: 21491031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
